Skip to main content

Find Clinical Trials

Home
Conditions
Slow Virus Diseases

Clinical trial condition

Slow Virus Diseases

Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.

2,616 public trials 184 recruiting studies

Refine in advanced search Browse all conditions

Slow Virus Diseases trial results

Completed

A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects

NCT01101893

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Buffalo, New York, United States

View Trial Details

Completed

Relative Bioavailability Study With BMS-955176

NCT02095886

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Nottingham, United Kingdom

View Trial Details

Completed

Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet

NCT02508064

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site Nottingham, United Kingdom

View Trial Details

Completed

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults

NCT02346084

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Magee Women's Hospital of UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

NCT02651376

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies

NCT00517803

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cancer, Second Primary, +16 more
Locations: St. Joseph's Hospital London, Ontario, Canada

View Trial Details

Completed

Nutritional Therapy Improves Dyslipidemia in HIV Infected Teenagers With Antiretroviral Treatment

NCT03021889

Conditions: Acquired Immunodeficiency Syndrome, Adolescent Behavior, Behavior, +20 more
Locations: Not specified

View Trial Details

Completed

Effect of Supplementation With Glutamine and Exercise in Women With HIV/AIDS

NCT03236532

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients

NCT00441688

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

NCT00756730

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Spectrum Medical Group Phoenix, Arizona, United States

AIDS Healthcare Foundation Los Angeles, California, United States

Orlando Immunology Center Orlando, Florida, United States

Community Research Initiative Boston, Massachusetts, United States

View Trial Details